Lumryz
Payments companies reported to CMS as associated with Lumryz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lumryz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lumryz
These are the largest totals companies reported as associated with Lumryz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jordan Dubow | Suffern, NY | Neurology (Psychiatry & Neurology) | $286,407.92 |
| Steven Gradney | Springfield, MO | Sleep Medicine (Internal Medicine) | $248,109.77 |
| Alon Avidan | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $167,651.22 |
| Anne Morse | Danville, PA | Neurology With Special Qualifications In Child Neurology | $147,237.77 |
| Gerard Meskill | Sugar Land, TX | Sleep Medicine (Psychiatry & Neurology) | $129,765.62 |
| Lewis Kass | Philadelphia, PA | Pediatric Pulmonology | $111,216.41 |
| Matthew Davis | Middletown, NJ | Neurology (Psychiatry & Neurology) | $108,212.45 |
| Murad Assaad | Atlanta, GA | Sleep Medicine (Internal Medicine) | $83,139.41 |
| Laura Herpel | Columbia, SC | Pulmonary Disease | $80,561.90 |
| Asim Roy | Dublin, OH | Sleep Medicine (Internal Medicine) | $69,064.77 |
Prescribed Lumryz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.